Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-019014-25Phase 2Active
Phase 2, randomised, single-blind trial of imatinib in brain infarction (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Safety and tolerability (serious and non-serious adverse events). Started May 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-019014-25.